Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of MiMedx Group Inc (NASDAQ: MDXG) violated securities laws in connection with certain financial statements.

The investigation seeks to discover if possible claims on behalf of purchasers of the securities of MiMedx Group Inc (NASDAQ: MDXG) concerning whether a series of statements by MiMedx Group Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On October 23, 2017, a report published by First Analysis made claims that the Company has “excluded (First Analysis) from asking questions on multiple calls while spending substantial time sparring with ‘short sellers’ and filing lawsuits.” In particular, well-known short-seller Marc Cohodes tweeted that he thinks MiMedx will not make it through their audit and calls on the Company's CEO to resign.

Following this news, shares of MiMedx dropped in value.

Based in Marietta, Georgia, and founded in 2008 MiMedx Group Inc develops and markets regenerative biologics utilizing human placental tissue allografts with patent-protected processes for various sectors of healthcare.

If you purchased shares of MiMedx Group Inc (NASDAQ: MDXG) on or before October 23, 2017, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com 

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/ 

or

Facsimile: +1 (619) 785 – 3185